Adipocyte-mediated expression of FGF-1, the ligand for FGFR-1, is elevated under conditions of obesity in mice and humans [92], suggesting that adipocytes may contribute to endocrine resistance through upregulation of FGF-1. Here, FGF1 is linked to obesity disorder.